NewGenIvf Group Ltd. Reports Interim Results for H1 2025
Ticker: NIVFW · Form: 6-K · Filed: Oct 9, 2025 · CIK: 1981662
| Field | Detail |
|---|---|
| Company | Newgenivf Group LTD (NIVFW) |
| Form Type | 6-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: interim-results, financial-reporting
TL;DR
NewGenIvf dropped H1 2025 interim results, check financials.
AI Summary
NewGenIvf Group Limited (NewGen) has filed its Form 6-K for October 2025, reporting its unaudited interim results for the six months ended June 30, 2025. The filing includes financial information for NewGen and its subsidiaries.
Why It Matters
This filing provides investors with an update on the company's financial performance for the first half of 2025, allowing them to assess its current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate material events or significant changes indicated.
Key Players & Entities
- NewGenIvf Group Limited (company) — Registrant
- June 30, 2025 (date) — End of interim reporting period
- October 2025 (date) — Reporting month
FAQ
What period do the interim results in this 6-K filing cover?
The interim results cover the six months ended June 30, 2025.
What is the name of the company filing this report?
The company filing this report is NewGenIvf Group Limited.
What form is being filed?
A Form 6-K is being filed.
What is the principal executive office address provided?
The principal executive office is located at 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand.
Does the registrant file annual reports under Form 20-F or Form 40-F?
The registrant indicates it files annual reports under Form 20-F.
Filing Stats: 276 words · 1 min read · ~1 pages · Grade level 14.8 · Accepted 2025-10-09 07:42:17
Filing Documents
- ea0260778-6k_newgenivf.htm (6-K) — 12KB
- ea026077801ex99-1_newgenivf.htm (EX-99.1) — 59KB
- 0001213900-25-097578.txt ( ) — 72KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-42004 NEWGENIVF GROUP LIMITED 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K Interim Results for the Six Months Ended June 30, 2025 The unaudited financial results for the six months ended June 30, 2025 (“Interim Results”) of NewGenIvf Group Limited (“NewGen”) and its subsidiaries (collectively, the “Company”) is furnished as Exhibit 99.1 to this report on Form 6-K. The unaudited financial information set out in this earnings release is subject to potential adjustments. Adjustments to the consolidated financial statements may be identified when audit work is performed for the Company’s year-end audit, which could result in significant differences from this unaudited financial information. 1 EXHBIT INDEX Exhibit No. Description 99.1 NewGenIvf Group Limited’s Unaudited Financial Results for the Six Months Ended June 30, 2025 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 9, 2025 NewGenIvf Group Limited By: /s/ Wing Fung Alfred Siu Name: Wing Fung Alfred Siu Title: Chairman of the Board and Director 3